Alyeska Investment Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-227,338
Closed -$23.6M 678
2026
Q1
$23.6M Buy
+227,338
New +$25.8M 0.07% 299
2021
Q1
Sell
-3,236
Closed -$653K 747
2020
Q4
$653K Sell
3,236
-1,999
-38% -$414K 0.01% 434
2020
Q3
$1.1M Buy
+5,235
New +$1.17M 0.02% 383
2019
Q3
Sell
-153,615
Closed -$23.5M 422
2019
Q2
$23.5M Buy
+153,615
New +$23.5M 0.3% 107
2017
Q4
Sell
-209,314
Closed -$27.6M 448
2017
Q3
$27.6M Buy
209,314
+6,150
+3% +$826K 0.21% 143
2017
Q2
$27.1M Buy
203,164
+173,535
+586% +$23.4M 0.23% 139
2017
Q1
$4M Sell
29,629
-256,180
-90% -$33.2M 0.03% 341
2016
Q4
$34.3M Buy
+285,809
New +$33.7M 0.28% 133

Other funds holding CLX

Alyeska Investment Group's CLX Position: Q2 2026 in Review

Alyeska Investment Group sold out of Clorox (CLX) in Q2 2026, closing a stake of 227,338 shares — an estimated $23.6M sold.

Alyeska Investment Group first reported a position in CLX in Q4 2016 and held it in 8 quarters. The position peaked at $34.3M in Q4 2016. 1,039 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Alyeska Investment Group reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Alyeska Investment Group sold 227,338 Clorox shares in Q2 2026, an estimated $23.6M.
  • Alyeska Investment Group first reported a position in Clorox in Q4 2016 and held it in 8 quarters.
  • Alyeska Investment Group's Clorox position peaked at $34.3M in Q4 2016.
  • 1,039 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.